Impact of the 2017 FDA Drug Safety Communication on Codeine and Tramadol Dispensing to Children

Pediatrics. 2022 Nov 1;150(5):e2021055887. doi: 10.1542/peds.2021-055887.

Authors

Madeline H Renny^{1

2}, Victoria Jent², Tarlise Townsend^{2

3}, Magdalena Cerdá²

Affiliations

¹ Departments of Emergency Medicine, Pediatrics, and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
² Center for Opioid Epidemiology and Policy, Department of Population Health, New York University Grossman School of Medicine, New York, New York.
³ Deceased.

No abstract available

Publication types

Research Support, U.S. Gov't, P.H.S.
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Analgesics, Opioid / adverse effects
Child
Codeine / adverse effects
Communication
Humans
Tramadol* / adverse effects

Substances

Tramadol
Codeine
Analgesics, Opioid

Grants and funding